Repassy G, Molnar A, Maihoub S, Hargas D, Tamas L
Eur Arch Otorhinolaryngol. 2025; .
PMID: 39961835
DOI: 10.1007/s00405-025-09229-8.
Zhao Y, Xue J
Heliyon. 2025; 11(1):e40832.
PMID: 39811326
PMC: 11730226.
DOI: 10.1016/j.heliyon.2024.e40832.
Che Z, Wan X, Xu J, Duan C, Zheng T, Chen J
Nat Commun. 2024; 15(1):1873.
PMID: 38472193
PMC: 10933441.
DOI: 10.1038/s41467-024-45915-7.
Zhong R, Zhan J, Zhang S
Appl Biochem Biotechnol. 2023; 196(7):3891-3913.
PMID: 37792175
DOI: 10.1007/s12010-023-04727-z.
Zahran M, Alsedra S, Youssef A
Indian J Otolaryngol Head Neck Surg. 2023; 75(3):1813-1818.
PMID: 37636696
PMC: 10447746.
DOI: 10.1007/s12070-023-03756-8.
Investigating miR-9 as a mediator in laryngeal cancer health disparities.
Gobin C, Inkabi S, Lattimore C, Gu T, Menefee J, Rodriguez M
Front Oncol. 2023; 13:1096882.
PMID: 37081981
PMC: 10112398.
DOI: 10.3389/fonc.2023.1096882.
Increased expression of Myosin X contributes to the metastasis in patients with laryngeal squamous cell carcinoma.
Deng G, Fu T, Liu C
Mol Genet Genomics. 2022; 297(6):1529-1536.
PMID: 35951144
PMC: 9596522.
DOI: 10.1007/s00438-022-01934-x.
Reconstruction of Pharyngolaryngeal Defects with the Ileocolon Free Flap: A Comprehensive Review and How to Optimize Outcomes.
Escandon J, Santamaria E, Prieto P, Duarte-Bateman D, Ciudad P, Pencek M
Arch Plast Surg. 2022; 49(3):378-396.
PMID: 35832153
PMC: 9142245.
DOI: 10.1055/s-0042-1748652.
CAPRIN1 Enhances Chemoresistance and Glycolysis in Laryngeal Squamous Cell Carcinoma via Regulation of ZIC5.
Zhang Y, Zhang H, Dong J, Zhao P, Hao F, Han H
J Oncol. 2022; 2022:6160539.
PMID: 35571493
PMC: 9098336.
DOI: 10.1155/2022/6160539.
Prognostic value of a microRNA-pair signature in laryngeal squamous cell carcinoma patients.
Zhou S, Meng Q, Wang Z
Eur Arch Otorhinolaryngol. 2022; 279(9):4451-4460.
PMID: 35478043
DOI: 10.1007/s00405-022-07404-9.
A metabolomics strategy to identify potential biomarkers associated with human laryngeal cancer based on dried blood spot mass spectrometry approach.
Wu X, Liu Y, Ao H, Yang P, Zhu Z
Medicine (Baltimore). 2022; 101(8):e28820.
PMID: 35212275
PMC: 8878607.
DOI: 10.1097/MD.0000000000028820.
Ribophorin II promotes the epithelial-mesenchymal transition and aerobic glycolysis of laryngeal squamous cell carcinoma via regulating reactive oxygen species-mediated Phosphatidylinositol-3-Kinase/Protein Kinase B activation.
Zhou J, Zhang J, Zhang W, Ke Z, Lv Y, Zhang B
Bioengineered. 2022; 13(3):5141-5151.
PMID: 35156537
PMC: 8974210.
DOI: 10.1080/21655979.2022.2036914.
Serum levels of microRNA-21 and microRNA-10a can predict long-term prognosis in laryngeal cancer patients: a multicenter study.
Gao S, Xu Q, Zhou Y, Yi Q
Transl Cancer Res. 2022; 9(5):3680-3690.
PMID: 35117730
PMC: 8797749.
DOI: 10.21037/tcr-20-1758.
Oncologic results and quality of life in patients with T3 glottic cancer after transoral laser microsurgery.
Chien P, Hung L, Wang L, Yang M, Chu P
Eur Arch Otorhinolaryngol. 2021; 278(8):2983-2992.
PMID: 33403435
DOI: 10.1007/s00405-020-06445-2.
LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.
Jing Z, Guo S, Zhang P, Liang Z
Technol Cancer Res Treat. 2020; 19:1533033820985787.
PMID: 33371795
PMC: 7780331.
DOI: 10.1177/1533033820985787.
FADS1 promotes the progression of laryngeal squamous cell carcinoma through activating AKT/mTOR signaling.
Zhao R, Tian L, Zhao B, Sun Y, Cao J, Chen K
Cell Death Dis. 2020; 11(4):272.
PMID: 32332698
PMC: 7181692.
DOI: 10.1038/s41419-020-2457-5.
The association between XRCC1 polymorphism and laryngeal cancer susceptibility in different ethnic groups in Xinjiang, China.
Alimu N, Qukuerhan A, Wang S, Abdurehim Y, Kuyaxi P, Zhang B
Int J Clin Exp Pathol. 2020; 11(9):4595-4604.
PMID: 31949858
PMC: 6962955.
Long non-coding RNA ANRIL promotes proliferation, clonogenicity, invasion and migration of laryngeal squamous cell carcinoma by regulating miR-181a/Snai2 axis.
Hao Y, Zhang D, Fu Z, Guo Y, Guan G
Regen Ther. 2019; 11:282-289.
PMID: 31667207
PMC: 6813643.
DOI: 10.1016/j.reth.2019.07.007.
MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma.
Li Y, Tao C, Dai L, Cui C, Chen C, Wu H
Biosci Rep. 2018; 39(1).
PMID: 30563928
PMC: 6340973.
DOI: 10.1042/BSR20181882.
Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
Zhao R, Li F, Tian L, Shang D, Guo Y, Zhang J
Funct Integr Genomics. 2018; 19(1):109-121.
PMID: 30128795
DOI: 10.1007/s10142-018-0631-y.